Clinical Trial Update: Neuro Biomarkers of Smoking Behavior [Phase 2]

View source ↗

Summary

Phase 2 trial assessing neuro biomarkers of smoking behavior was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Smoking Cessation | Phase 2 | Status: TERMINATED | Results posted: 2021-03-02